Polyrizon Ltd.

1.01
-0.11 (-9.82%)
At close: Feb 10, 2025, 3:59 PM
1.03
1.98%
After-hours Feb 10, 2025, 07:55 PM EST
undefined%
Bid 1.01
Market Cap 4.24M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -0.24
PE Ratio (ttm) -4.21
Forward PE n/a
Analyst n/a
Ask 1.06
Volume 122,305
Avg. Volume (20D) 2,987,900
Open 1.01
Previous Close 1.12
Day's Range 1.00 - 1.09
52-Week Range 0.77 - 4.80
Beta undefined

About PLRZ

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel....

Industry Biotechnology
Sector Healthcare
IPO Date Oct 29, 2024
Employees 1
Stock Exchange NASDAQ
Ticker Symbol PLRZ
1 month ago
+31.71%
Polyrizon shares are trading higher after the comp... Unlock content with Pro Subscription
1 month ago
+213.33%
PolyRizon shares are trading higher after the company announced it secured a GMP partnership with Eurofins CDO Amatsiaquitaine.
No News article available yet